Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
20.59
+0.31 (1.53%)
At close: May 2, 2024, 4:00 PM
19.00
-1.59 (-7.72%)
After-hours: May 2, 2024, 7:37 PM EDT

Kura Oncology Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
142
Market Cap
1.57B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.06B
Taro Pharmaceutical Industries 610.83M
U.S. Physical Therapy 604.80M
Veracyte 361.05M
Zai Lab 266.72M
ADMA Biologics 258.22M
Ardelyx 124.46M
Revenue Rankings